Form 4: GoodRx Holdings Executive Romin Nabiey Reports Stock Transactions
SEC Form 4 Filing
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the vesting and subsequent disposal of Class A Common Stock to cover tax obligations.
Summary
- On March 8, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock.
- 10,201 restricted stock units vested and were converted into Class A Common Stock.
- Following the vesting, 3,745 shares were disposed of at a price of $7.54 to satisfy tax obligations.
- After these transactions, Nabiey directly owns 115,997 shares of Class A Common Stock and 102,008 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation activities.
Key Dates
| Date | Description |
|---|---|
| December 8, 2022 | Initial vesting date for the restricted stock unit award (6.25% of underlying shares). |
| March 8, 2024 | Date of the reported transactions: vesting of restricted stock units and disposal of shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.